187 related articles for article (PubMed ID: 25884277)
1. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis.
Chaudhury B; Zhou M; Goldgof DB; Hall LO; Gatenby RA; Gillies RJ; Patel BK; Weinfurtner RJ; Drukteinis JS
J Magn Reson Imaging; 2015 Nov; 42(5):1421-30. PubMed ID: 25884277
[TBL] [Abstract][Full Text] [Related]
2. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
4. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
5. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
7. Textural kinetics: a novel dynamic contrast-enhanced (DCE)-MRI feature for breast lesion classification.
Agner SC; Soman S; Libfeld E; McDonald M; Thomas K; Englander S; Rosen MA; Chin D; Nosher J; Madabhushi A
J Digit Imaging; 2011 Jun; 24(3):446-63. PubMed ID: 20508965
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
9. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
10. Differentiating axillary lymph node metastasis in invasive breast cancer patients: A comparison of radiomic signatures from multiparametric breast MR sequences.
Chai R; Ma H; Xu M; Arefan D; Cui X; Liu Y; Zhang L; Wu S; Xu K
J Magn Reson Imaging; 2019 Oct; 50(4):1125-1132. PubMed ID: 30848041
[TBL] [Abstract][Full Text] [Related]
11. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
Wang C; Wei W; Santiago L; Whitman G; Dogan B
Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
14. Using quantitative image analysis to classify axillary lymph nodes on breast MRI: a new application for the Z 0011 Era.
Schacht DV; Drukker K; Pak I; Abe H; Giger ML
Eur J Radiol; 2015 Mar; 84(3):392-397. PubMed ID: 25547328
[TBL] [Abstract][Full Text] [Related]
15. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study.
van Nijnatten TJA; Schipper RJ; Lobbes MBI; van Roozendaal LM; Vöö S; Moossdorff M; Paiman ML; de Vries B; Keymeulen KBMI; Wildberger JE; Smidt ML; Beets-Tan RGH
Clin Radiol; 2018 Feb; 73(2):168-175. PubMed ID: 29029766
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy.
Loiselle CR; Eby PR; DeMartini WB; Peacock S; Bittner N; Lehman CD; Kim JN
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1314-9. PubMed ID: 19604652
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of benign and metastatic axillary lymph nodes in breast cancer: additive value of MRI computer-aided evaluation.
Yun SJ; Sohn YM; Seo M
Clin Radiol; 2016 Apr; 71(4):403.e1-7. PubMed ID: 26875621
[TBL] [Abstract][Full Text] [Related]
19. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
20. Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?
Rahbar H; Conlin JL; Parsian S; DeMartini WB; Peacock S; Lehman CD; Partridge SC
Acad Radiol; 2015 Apr; 22(4):430-8. PubMed ID: 25491740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]